Ranbaxy Cleared To Launch Diovan Generic In U.S. With Exclusivity
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories is free to launch its generic version of the Novartis drug Diovan (valsartan) for treating high blood pressure in the U.S. after gaining U.S. FDA approval.